Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Moderna Stock Futures: Is COVID Vaccine Maker Moderna Poised To Pop Or Drop?
08:45am, Tuesday, 29'th Nov 2022
Based on that assumption, this would indicate that the annual demand for COVID vaccines would be around 600 million doses.
Moderna to Present at the Piper Sandler 34th Annual Healthcare Conference
08:00am, Tuesday, 29'th Nov 2022
CAMBRIDGE, MA / ACCESSWIRE / November 29, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in a
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
05:36pm, Monday, 28'th Nov 2022 MarketWatch
Widespread protests across China over the government's zero-COVID policy dominated headlines on the pandemic on Monday.
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
05:30pm, Monday, 28'th Nov 2022 Zacks Investment Research
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
China's zero COVID strategy 'doesn't make public health sense,' says Fauci
09:13am, Monday, 28'th Nov 2022 MarketWatch
President Joe Biden's chief medical adviser, Dr. Anthony Fauci, says China's COVID-19 strategy of lockdowns without a better vaccination strategy doesn't make
11% Of S&P 500 Stocks Suffer Their Worst Year Ever
08:00am, Monday, 28'th Nov 2022
Tesla isn't the only stock that's struggling in 2022. Nearly 60 S&P 500 stocks — or about 11% — are having their worst year ever.
Is Novavax Stock a Buy Now?
03:37pm, Saturday, 26'th Nov 2022 The Motley Fool
There's probably not much good news coming for this biotech in the near future.
The Worst Mistake Moderna Investors Can Make in 2023
11:00am, Saturday, 26'th Nov 2022 The Motley Fool
Moderna faces a major transition in 2023.
The Worst Mistake Moderna Investors Can Make in 2023
06:00am, Saturday, 26'th Nov 2022
Moderna faces a major transition in 2023.
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
05:47pm, Thursday, 24'th Nov 2022 MarketWatch
Less than 11% of Americans have opted to get the bivalent COVID-19 booster shot ahead of another pandemic winter and holiday season.
Novavax Stock: Buy, Sell, or Hold in 2023?
11:00am, Thursday, 24'th Nov 2022 The Motley Fool
The shares are heading for almost a 90% loss this year.
7 Stocks on the Perfect 10 List
06:47pm, Wednesday, 23'rd Nov 2022
A stock that scores a perfect 10 should be on every investor's list of stocks to buy. Any company that receives full marks on quality, value, or growth are stocks I'd considering a perfect 10.
Novavax (NVAX) Cancels COVID Jab Supply Deal With GAVI
05:35pm, Wednesday, 23'rd Nov 2022 Zacks Investment Research
Novavax (NVAX) claims that GAVI's failure to procure its COVID vaccine doses is a reason to terminate the supply agreement. GAVI denies the company's claims and a legal battle is likely to follow.
Buy this Medical Sector Pioneer Stock
04:53pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Gilead Sciences (GILD) is up roughly 20% since its Q3 release in October, let's take a look at what could continue propelling GILD stock.
